Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Double Blinded, Placebo Controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics and Acute Cardiovascular Responses of a 7 Day Oral Treatment With the Partial Adenosine A1 Receptor Agonist BAY1067197 in Patients With Chronic Systolic Heart Failure: the PARSiFAL-pilot Study https://www.kusajili.com:443/Trial/hRIVgwgSpkS310T_2ecHAg%24a-double-blinded-placebo-controlled-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-acute-cardiovascular-resp
I have read and accept the terms of use of the site and the Privacy Policy
Send your message